About the Company
We do not have any company description for VivoSim Labs, INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on VivoSim Labs, INC.
VivoSim Labs, Inc.: VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer
VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a pharmaceutical and biotechnology services company that is focused on providing testing ...
VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To ...
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development.
VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at ...
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced today that its world-leading NAMkind™ platform for liver toxicology prediction ...
VivoSim Labs Inc News (VIVS) - Investing.com
VivoSim Labs introduces AI-driven drug testing models SAN DIEGO - VivoSim Labs, Inc. (NASDAQ:VIVS), a biotechnology firm with a market capitalization of $2.97 million, has announced ...
VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive ...
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized ...
VivoSim Labs Inc
VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary ...
VIVS | VivoSim Labs Inc. Annual Income Statement | MarketWatch
VivoSim Labs Inc. Annual stock financials by MarketWatch. View the latest VIVS financial statements, income statements and financial ratios.
VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer
Veteran commercial leader to scale AI-enabled NAMkind™ liver and intestine toxicology services in a rapidly growing marketSAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) ...
VivoSim Labs Appoints New Chief Commercial Officer
VivoSim Labs ( (VIVS) ) has issued an announcement. On August 7, 2025, VivoSim Labs appointed Tony Lialin as Chief Commercial Officer, effective August 11, 2025. Lialin, with over two decades of ...
VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at ...
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced today that its world-leading NAMkind™ platform for liver toxicology prediction, provided as a ...
VivoSim Labs Inc News (VIVS) - Investing.com
Organovo Holdings Inc. (NASDAQ:ONVO), a pioneering company in the field of bioprinting, has reached a 52-week high, with its ...
Similar Companies
Loading the latest forecasts...